Literature DB >> 11071369

Extracellular concentrations of taurine, glutamate, and aspartate in the cerebral cortex of rats at the asymptomatic stage of thioacetamide-induced hepatic failure: modulation by ketamine anesthesia.

J Albrecht1, W Hilgier, M Zielińska, S Januszewski, M Hesselink, G Quack.   

Abstract

Subclinical hepatic encephalopathy (SHE) was produced in rats by two intraperitoneal injections of TAA at 24 h intervals and the animals were examined 21 days later. Concentrations of the neuroactive amino acids taurine (Tau), glutamate (Glu) and aspartate (Asp), were measured in the cerebral cortical microdialysates of thioacetamide (TAA)-treated and untreated control rats. During microdialysis some animals were awake while others were anesthetized with ketamine plus xylazine. There was no difference in the water content of cerebral cortical slices isolated from control and SHE rats, indicating a recovery from cerebral cortical edema that accompanies the acute, clinical phase of hepatic encephalopathy in this model. When microdialysis was carried out in awake rats, dialysate concentrations of all the three amino acids were 30% to 50% higher in SHE rats than in control rats. Ketamine anesthesia caused a 2.2% increase of water content of cerebral cortical slices and increased Asp, Glu, and Tau concentration in microdialysates of control rats. In SHE rats, ketamine anesthesia produced a similar degree of cerebral edema, however, it did not alter Asp and Glu concentrations in the microdialysates. These data may reflect on one hand a neuropathological process of excitotoxic neuronal damage related to increased Glu and Asp, on the other hand neuroprotection from neuronal swelling indicated by Tau redistribution in the cerebral cortex. The reduction of the effects of SHE on Glu and Asp content in ketamine-anesthesized rats is likely to be due to interference of ketamine with the NMDA receptor-mediated component of the SHE-evoked excitatory neurotransmitter efflux and/or reuptake of the two amino acids. By contrast, the SHE-related increase of Tau content was not affected by ketamine anesthesia, indicating that the mechanism(s) underlying SHE-evoked accumulation of Tau must be different from the mechanism causing release of excitatory amino acids. The results with ketamine advocate caution when using this anesthetic in studies employing the cerebral microdialysis technique for measurement of extracellular amino acids.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11071369     DOI: 10.1023/a:1007680210114

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  36 in total

1.  Taurine increases in the nucleus accumbens microdialysate after acute ethanol administration to naive and chronically alcoholised rats.

Authors:  A Dahchour; E Quertemont; P De Witte
Journal:  Brain Res       Date:  1996-09-30       Impact factor: 3.252

2.  Comparison of the uptake of [3H]glutamate into rat cerebrocortical and cerebellar synaptosomes. Effects of anaesthetic agents.

Authors:  B Nicol; D J Rowbotham; D G Lambert
Journal:  Biochem Soc Trans       Date:  1994-11       Impact factor: 5.407

3.  Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure.

Authors:  W Hilgier; M Zielińska; H D Borkowska; R Gadamski; M Walski; S S Oja; P Saransaari; J Albrecht
Journal:  J Neurosci Res       Date:  1999-04-01       Impact factor: 4.164

4.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

5.  Lectin histochemistry of the rat brain following thioacetamide-induced hepatic failure.

Authors:  G Szumańska; J Albrecht
Journal:  Mol Chem Neuropathol       Date:  1997 Sep-Dec

6.  Flumazenil does not affect the increase in rat hippocampal extracellular glutamate concentration produced during thioacetamide-induced hepatic encephalopathy.

Authors:  P McArdle; D H Penning; F Dexter; J D Reynolds
Journal:  Metab Brain Dis       Date:  1996-12       Impact factor: 3.584

7.  Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover.

Authors:  G Quack; M Hesselink; W Danysz; R Spanagel
Journal:  J Neural Transm Suppl       Date:  1995

8.  Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure.

Authors:  A Michalak; C Rose; J Butterworth; R F Butterworth
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

9.  Neuronal-glial exchange of taurine during hypo-osmotic stress: a combined immunocytochemical and biochemical analysis in rat cerebellar cortex.

Authors:  E A Nagelhus; A Lehmann; O P Ottersen
Journal:  Neuroscience       Date:  1993-06       Impact factor: 3.590

10.  Release of taurine from astrocytes during potassium-evoked swelling.

Authors:  H Pasantes-Morales; A Schousboe
Journal:  Glia       Date:  1989       Impact factor: 7.452

View more
  11 in total

1.  Rapid changes in glutamate levels in the posterior hypothalamus across sleep-wake states in freely behaving rats.

Authors:  Joshi John; Lalini Ramanathan; Jerome M Siegel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-24       Impact factor: 3.619

Review 2.  The role of excitatory amino acid transporters in cerebral ischemia.

Authors:  Xiao-dong Chao; Fei Fei; Zhou Fei
Journal:  Neurochem Res       Date:  2010-05-04       Impact factor: 3.996

3.  The role of protein kinase C and cyclic AMP in the ammonia-induced shift of the taurine uptake/efflux balance towards efflux in C6 cells.

Authors:  Magdalena Zielińska; Barbara Zabłocka; Anna Dybel; Jan Albrecht
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

4.  The Involvement of the Decrease of Astrocytic Wnt5a in the Cognitive Decline in Minimal Hepatic Encephalopathy.

Authors:  Saidan Ding; Zhu Xu; Jianjing Yang; Leping Liu; Xueli Huang; Xuebao Wang; Qichuan Zhuge
Journal:  Mol Neurobiol       Date:  2016-11-22       Impact factor: 5.590

5.  Genistein Alleviates Neuroinflammation and Restores Cognitive Function in Rat Model of Hepatic Encephalopathy: Underlying Mechanisms.

Authors:  Ajaz Ahmad Ganai; Mohammad Husain
Journal:  Mol Neurobiol       Date:  2017-02-21       Impact factor: 5.590

6.  Ammonia-induced extracellular accumulation of taurine in the rat striatum in vivo: role of ionotropic glutamate receptors.

Authors:  M Zielińska; W Hilgier; H D Borkowska; S S Oja; P Saransaari; P Goryński; J Albrecht
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

Review 7.  The role of inhibitory amino acidergic neurotransmission in hepatic encephalopathy: a critical overview.

Authors:  Jan Albrecht; Magdalena Zielińska
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

8.  DA Negatively Regulates IGF-I Actions Implicated in Cognitive Function via Interaction of PSD95 and nNOS in Minimal Hepatic Encephalopathy.

Authors:  Saidan Ding; Weishan Zhuge; Xuebao Wang; Jianjing Yang; Yuanshao Lin; Chengde Wang; Jiangnan Hu; Qichuan Zhuge
Journal:  Front Cell Neurosci       Date:  2017-09-06       Impact factor: 5.505

9.  An optimized fluorescent probe for visualizing glutamate neurotransmission.

Authors:  Jonathan S Marvin; Bart G Borghuis; Lin Tian; Joseph Cichon; Mark T Harnett; Jasper Akerboom; Andrew Gordus; Sabine L Renninger; Tsai-Wen Chen; Cornelia I Bargmann; Michael B Orger; Eric R Schreiter; Jonathan B Demb; Wen-Biao Gan; S Andrew Hires; Loren L Looger
Journal:  Nat Methods       Date:  2013-01-13       Impact factor: 28.547

Review 10.  Contributions of microdialysis to new alternative therapeutics for hepatic encephalopathy.

Authors:  Liliana Rivera-Espinosa; Esaú Floriano-Sánchez; José Pedraza-Chaverrí; Elvia Coballase-Urrutia; Aristides Iii Sampieri; Daniel Ortega-Cuellar; Noemí Cárdenas-Rodríguez; Liliana Carmona-Aparicio
Journal:  Int J Mol Sci       Date:  2013-08-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.